Omeros (OMER) Net Income (2010 - 2026)
Omeros recorded quarterly Net Income of $4.8 million in Q1 2026, down 26.67% quarter-over-quarter from $6.6 million in Q4 2025, and up 17.2% year-over-year from $4.1 million in Q1 2025.
Omeros' Net Income history runs 17 years deep, the most recent figure standing at $4.8 million for Q1 2026.
- In Q1 2026, Net Income rose 17.2% year-over-year to $4.8 million; the TTM figure through Mar 2026 stood at $2.2 million (down 90.69% YoY), while the FY2025 annual figure was $1.5 million, down 94.35% from the prior year.
- Net Income came in at $4.8 million for Q1 2026 at Omeros, down from $6.6 million in the prior quarter.
- In the past five years, Net Income ranged from a high of $174.8 million in Q4 2022 to a low of -$9.7 million in Q3 2025.
- A 5-year average of $18.7 million and a median of $6.6 million in 2025 frame the typical range for Net Income.
- Across the five-year window, Net Income jumped 73.05% in 2022 and slumped 298.2% in 2025, its largest moves.
- Omeros' Net Income stood at $174.8 million in 2022, then plunged by 82.71% to $30.2 million in 2023, then tumbled by 82.85% to $5.2 million in 2024, then rose by 26.59% to $6.6 million in 2025, then fell by 26.67% to $4.8 million in 2026.
- According to Business Quant data, Net Income over the past three periods registered $4.8 million, $6.6 million, and -$9.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.99 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -8.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -14.46 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.03 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3.40 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 727.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 205.99 Mn |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn | 4.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.81 Mn |
| Dec 31, 2025 | 6.56 Mn |
| Sep 30, 2025 | -9.67 Mn |
| Jun 30, 2025 | 466,000.00 |
| Mar 31, 2025 | 4.11 Mn |
| Dec 31, 2024 | 5.18 Mn |
| Sep 30, 2024 | 4.88 Mn |
| Jun 30, 2024 | 9.08 Mn |
| Mar 31, 2024 | 6.67 Mn |
| Dec 31, 2023 | 30.22 Mn |
| Sep 30, 2023 | 13.91 Mn |
| Jun 30, 2023 | 7.00 Mn |
| Mar 31, 2023 | 5.98 Mn |
| Dec 31, 2022 | 174.78 Mn |
| Sep 30, 2022 | 37.34 Mn |
| Jun 30, 2022 | 10.85 Mn |
| Mar 31, 2022 | 6.48 Mn |
| Dec 31, 2021 | 327.93 Mn |
| Sep 30, 2021 | 21.58 Mn |
| Jun 30, 2021 | 21.59 Mn |
| Mar 31, 2021 | 14.68 Mn |
| Dec 31, 2020 | -72.30 Mn |
| Sep 30, 2020 | -38.46 Mn |
| Jun 30, 2020 | -33.66 Mn |
| Mar 31, 2020 | -29.58 Mn |
| Dec 31, 2019 | -111.88 Mn |
| Sep 30, 2019 | -16.46 Mn |
| Jun 30, 2019 | -14.87 Mn |
| Mar 31, 2019 | -24.84 Mn |
| Dec 31, 2018 | -23.62 Mn |
| Sep 30, 2018 | -40.04 Mn |
| Jun 30, 2018 | -34.29 Mn |
| Mar 31, 2018 | -30.51 Mn |
| Dec 31, 2017 | -16.99 Mn |
| Sep 30, 2017 | -7.89 Mn |
| Jun 30, 2017 | -14.66 Mn |
| Mar 31, 2017 | -15.39 Mn |
| Dec 31, 2016 | -14.31 Mn |
| Sep 30, 2016 | -14.17 Mn |
| Jun 30, 2016 | -12.79 Mn |
| Mar 31, 2016 | -20.83 Mn |
| Dec 31, 2015 | -18.85 Mn |
| Sep 30, 2015 | -20.17 Mn |
| Jun 30, 2015 | -16.90 Mn |
| Mar 31, 2015 | -18.89 Mn |
| Dec 31, 2014 | -21.10 Mn |
| Sep 30, 2014 | -18.07 Mn |
| Jun 30, 2014 | -18.15 Mn |
| Mar 31, 2014 | -16.35 Mn |
| Dec 31, 2013 | -13.92 Mn |
| Sep 30, 2013 | -14.02 Mn |
| Jun 30, 2013 | -13.75 Mn |
| Mar 31, 2013 | -10.60 Mn |
| Dec 31, 2012 | -7.89 Mn |
| Sep 30, 2012 | -13.44 Mn |
| Jun 30, 2012 | -8.69 Mn |
| Mar 31, 2012 | -8.55 Mn |
| Dec 31, 2011 | -10.37 Mn |
| Sep 30, 2011 | -6.68 Mn |
| Jun 30, 2011 | -5.46 Mn |
| Mar 31, 2011 | -6.73 Mn |
| Dec 31, 2010 | -8.85 Mn |
| Sep 30, 2010 | -7.74 Mn |
| Jun 30, 2010 | -8.02 Mn |